This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:ibd [02.17.2019] – [Inflammatory bowel disease (Crohn's disease and ulcerative colitis)] sallieq | home:diseases:ibd [03.21.2019] – [Patient interviews] sallieq | ||
---|---|---|---|
Line 4: | Line 4: | ||
- | <relatedarticle> [[home: | + | <relatedarticles> [[home: |
===== Introduction ===== | ===== Introduction ===== | ||
Line 181: | Line 181: | ||
===== Research ===== | ===== Research ===== | ||
+ | |||
+ | Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely. | ||
+ | |||
+ | In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity. | ||
Development, | Development, | ||
< | < | ||
- | |||
Using a functional peptide cleavage assay it was shown that epithelial cells secreted proteolytic active enzymes and that the functional MMP activity was increased in inflamed IBD mucosa. | Using a functional peptide cleavage assay it was shown that epithelial cells secreted proteolytic active enzymes and that the functional MMP activity was increased in inflamed IBD mucosa. | ||
- | Our results revealed that colonic epithelial cells express TLR9, a key pattern recognition receptor. Interestingly, | + | Our results revealed that colonic epithelial cells express TLR9, a key pattern recognition receptor. Interestingly, |
+ | </ | ||
' | ' | ||
- | [[https://www.sciencemag.org/news/2018/11/do-gut-bacteria-make-second-home-our-brains|Roberts doesn’t know how these bacteria could have gotten into the brain. They may have crossed from blood vessels, traveling up nerves from the gut, or even come in through the nose]] | + | Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. |
- | | + | |
- | ===== Patient interviews | + | Butyric acid in functional constipation |
+ | Butyric acid in irritable bowel syndrome | ||
+ | | ||
+ | [[https:// | ||
- | < | + | [[https://www.karger.com/Article/FullText/477386|Resistant Starch Regulates Gut Microbiota: Structure, |
- | <div class=" | + | Biochemistry and Cell Signalling]] |
- | + | ||
- | < | + | |
- | <div class=" | + | |
- | <div class=" | + | |
- | <div class=" | + | |
- | <div class=" | + | |
- | + | ||
- | Lyme disease, irritable bowel syndrome/ | + | |
- | + | ||
- | Read the [[http://bacteriality.com/2008/02/ | + | |
- | < | + | [{{: |
- | <br clear=" | ||
- | </ | ||
- | </ | ||
- | Interviews of patients with other diseases are [[home: | ||
{{tag> | {{tag> |